Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “Spinocerebellar Ataxia Genotype Type 1”
Phase 3 1
- TroriluzoleBiohaven Ltd.Spinocerebellar Ataxia Genotype Type 1; Spinocerebellar Ataxia Genotype Type 10
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.